The previous page is sending you to http://www.prnewswire.com/news-releases/amgen-presents-new-data-from-phase-3-xgeva-denosumab-study-in-patients-with-multiple-myeloma-at-asco-2017-300468299.html.

 If you do not want to visit that page, you can return to the previous page.